StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMApr 30, 2026, 07:06 AM

FHTX Sets 2026 Annual Meeting for June 24; Elects Directors

AI Summary

Foghorn Therapeutics Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 24, 2026. Stockholders will vote on the election of three Class III directors, the ratification of Deloitte & Touche LLP as the independent auditor, and advisory proposals regarding executive compensation and its frequency. The record date for voting is April 27, 2026.

Key Highlights

  • 2026 Annual Meeting of Stockholders to be held virtually on June 24, 2026, at 9 a.m. Eastern Time.
  • Stockholders to elect Douglas Cole, Balkrishan Gill, and B. Lynne Parshall as Class III directors for three-year terms.
  • Proposal to ratify Deloitte & Touche LLP as independent registered public accounting firm for fiscal year 2026.
  • Advisory vote on the compensation of Foghorn's named executive officers.
  • Advisory vote on the frequency of future advisory votes on executive compensation.
  • Record date for voting is April 27, 2026, with 58,713,922 shares outstanding.